当前位置:首页 - 行情中心 - 海特生物(300683) - 财务分析 - 现金流量表

海特生物

(300683)

  

流通市值:40.62亿  总市值:43.56亿
流通股本:1.22亿   总股本:1.31亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金372,277,047.5253,376,022.67118,255,513.66569,099,446.94
  收到的税费返还130,782.37131,844.0620,109.732,273,668.43
  收到其他与经营活动有关的现金20,121,993.439,604,969.815,872,748.92116,850,407.68
  经营活动现金流入小计392,529,823.3263,112,836.54124,148,372.31688,223,523.05
  购买商品、接受劳务支付的现金119,501,849.0579,396,886.3439,092,289.11199,996,912.6
  支付给职工以及为职工支付的现金199,457,004.73138,775,375.3983,310,135284,298,654.77
  支付的各项税费18,997,071.7815,883,844.757,923,047.0130,158,529.03
  支付其他与经营活动有关的现金130,614,231.4287,129,414.7243,615,703.38151,083,584.94
  经营活动现金流出小计468,570,156.98321,185,521.2173,941,174.5665,537,681.34
  经营活动产生的现金流量净额-76,040,333.68-58,072,684.66-49,792,802.1922,685,841.71
二、投资活动产生的现金流量:
  收回投资收到的现金904,650,000469,927,870.64200,006,237.011,854,360,000
  取得投资收益收到的现金4,097,617.373,616,716.38910,971.5218,197,341.2
  处置固定资产、无形资产和其他长期资产收回的现金净额473,473.5149,000-16,884.34
  收到的其他与投资活动有关的现金---1,000,000
  投资活动现金流入小计909,221,090.88473,593,587.02200,917,208.531,873,574,225.54
  购建固定资产、无形资产和其他长期资产支付的现金47,579,526.3429,731,962.9913,473,392.6643,080,104.97
  投资支付的现金973,800,000531,184,452.46375,729,677.911,924,445,710.5
  支付其他与投资活动有关的现金39,759,621.88185,536.49-6,393,695
  投资活动现金流出小计1,061,139,148.22561,101,951.94389,203,070.571,973,919,510.47
  投资活动产生的现金流量净额-151,918,057.34-87,508,364.92-188,285,862.04-100,345,284.93
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,000,0004,000,000-6,852,500
  其中:子公司吸收少数股东投资收到的现金---6,852,500
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计4,000,0004,000,000-6,852,500
  偿还债务支付的现金4,075,491.533,254,618.662,296,894.8314,600,000
  分配股利、利润或偿付利息支付的现金17,691,935.3917,436,607.3917,310,828.161,761,277.59
  支付其他与筹资活动有关的现金3,861,732.661,306,636.33692,2883,919,770.65
  筹资活动现金流出小计25,629,159.5821,997,862.3820,300,010.9920,281,048.24
  筹资活动产生的现金流量净额-21,629,159.58-17,997,862.38-20,300,010.99-13,428,548.24
四、汇率变动对现金及现金等价物的影响1,699.94737.53-43,309.67
五、现金及现金等价物净增加额-249,585,850.66-163,578,174.43-258,378,675.22-91,044,681.79
  加:期初现金及现金等价物余额419,120,360.56419,120,360.56419,120,360.56510,165,042.35
  期末现金及现金等价物余额169,534,509.9255,542,186.13160,741,685.34419,120,360.56
补充资料:
  净利润--40,202,379.5--73,769,864.46
  资产减值准备-6,804,040.36-28,632,712.08
  固定资产和投资性房地产折旧-31,349,225.57-61,834,938.18
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-31,349,225.57-61,834,938.18
  无形资产摊销-11,859,259.14-26,185,239.45
  长期待摊费用摊销-1,923,408.32-4,094,052.22
  处置固定资产、无形资产和其他长期资产的损失-572.48-65,217.91
  固定资产报废损失-69,202.92-1,146,767.3
  公允价值变动损失--5,136,870.6-908,853.74
  财务费用-748,297.18-2,317,055.6
  投资损失--12,692,210.67--16,698,740.87
  递延所得税--1,780,670.71--12,210,277.16
  其中:递延所得税资产减少--1,567,778.62--10,467,513.68
    递延所得税负债增加--212,892.09--1,742,763.48
  存货的减少-7,259,266.72--1,531,635.99
  经营性应收项目的减少--5,508,690.91--51,755,278.32
  经营性应付项目的增加--54,639,432.6-49,205,634.92
  现金的期末余额-255,542,186.13-419,120,360.56
  减:现金的期初余额-419,120,360.56-510,165,042.35
  现金及现金等价物的净增加额--163,578,174.43--91,044,681.79
公告日期2025-10-232025-08-262025-04-212025-04-21
审计意见(境内)标准无保留意见
TOP↑